Yuan Ziyang, Yu Haomiao, Long Huibin, Dai Yike, Shi Lin, Zhao Jiaming, Guo Ai, Diao Naicheng, Ma Lifeng, Yin Heyong
Department of Orthopaedics, Beijing Friendship Hospital, Capital Medical University, Beijing 100053, China.
Stem Cells Int. 2023 Mar 15;2023:3656498. doi: 10.1155/2023/3656498. eCollection 2023.
Tendons are associated with a high injury risk because of their overuse and age-related tissue degeneration. Thus, tendon injuries pose great clinical and economic challenges to the society. Unfortunately, the natural healing capacity of tendons is far from perfect, and they respond poorly to conventional treatments when injured. Consequently, tendons require a long period of healing and recovery, and the initial strength and function of a repaired tendon cannot be completely restored as it is prone to a high rate of rerupture. Nowadays, the application of various stem cell sources, including mesenchymal stem cells (MSCs) and embryonic stem cells (ESCs), for tendon repair has shown great potential, because these cells can differentiate into a tendon lineage and promote functional tendon repair. However, the mechanism underlying tenogenic differentiation remains unclear. Moreover, no widely adopted protocol has been established for effective and reproducible tenogenic differentiation because of the lack of definitive biomarkers for identifying the tendon differentiation cascades. This work is aimed at reviewing the literature over the past decade and providing an overview of background information on the clinical relevance of tendons and the urgent need to improve tendon repair; the advantages and disadvantages of different stem cell types used for boosting tendon repair; and the unique advantages of reported strategies for tenogenic differentiation, including growth factors, gene modification, biomaterials, and mechanical stimulation.
由于过度使用和与年龄相关的组织退变,肌腱具有较高的损伤风险。因此,肌腱损伤给社会带来了巨大的临床和经济挑战。不幸的是,肌腱的自然愈合能力远非完美,受伤时对传统治疗反应不佳。因此,肌腱需要很长时间的愈合和恢复,而且修复后的肌腱初始强度和功能无法完全恢复,因为其再断裂率很高。如今,包括间充质干细胞(MSCs)和胚胎干细胞(ESCs)在内的各种干细胞来源在肌腱修复中的应用已显示出巨大潜力,因为这些细胞可以分化为肌腱谱系并促进功能性肌腱修复。然而,成腱分化的潜在机制仍不清楚。此外,由于缺乏用于识别肌腱分化级联的明确生物标志物,尚未建立广泛采用的有效且可重复的成腱分化方案。这项工作旨在回顾过去十年的文献,并概述有关肌腱临床相关性的背景信息以及改善肌腱修复的迫切需求;用于促进肌腱修复的不同干细胞类型的优缺点;以及报道的成腱分化策略的独特优势,包括生长因子、基因修饰、生物材料和机械刺激。